39 related articles for article (PubMed ID: 22086394)
21. The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.
Liu P; Gou M; Yi T; Qi X; Xie C; Zhou S; Deng H; Wei Y; Zhao X
Int J Oncol; 2012 Oct; 41(4):1504-12. PubMed ID: 22825572
[TBL] [Abstract][Full Text] [Related]
22. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
Yang F; Gou M; Deng H; Yi T; Zhong Q; Wei Y; Zhao X
Oncol Rep; 2012 Aug; 28(2):668-76. PubMed ID: 22684947
[TBL] [Abstract][Full Text] [Related]
23. Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels.
Bai Y; Gou M; Yi T; Yang L; Liu L; Lin X; Su D; Wei Y; Zhao X
Int J Med Sci; 2015; 12(5):397-406. PubMed ID: 26005374
[TBL] [Abstract][Full Text] [Related]
24. Efficient inhibition of ovarian cancer by truncation mutant of FILIP1L gene delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
Xie C; Gou ML; Yi T; Deng H; Li ZY; Liu P; Qi XR; He X; Wei Y; Zhao X
Hum Gene Ther; 2011 Nov; 22(11):1413-22. PubMed ID: 21513424
[TBL] [Abstract][Full Text] [Related]
25. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
26. Biological characterization of ovarian cancer: prognostic and therapeutic implications.
Legge F; Ferrandina G; Salutari V; Scambia G
Ann Oncol; 2005 May; 16 Suppl 4():iv95-101. PubMed ID: 15923439
[No Abstract] [Full Text] [Related]
27. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.
Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X
Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394
[TBL] [Abstract][Full Text] [Related]
28. Zebrafish xenografts as a tool for in vivo studies on human cancer.
Konantz M; Balci TB; Hartwig UF; Dellaire G; André MC; Berman JN; Lengerke C
Ann N Y Acad Sci; 2012 Aug; 1266():124-37. PubMed ID: 22901264
[TBL] [Abstract][Full Text] [Related]
29. Cationic polymer nanoparticles and nanogels: from synthesis to biotechnological applications.
Ramos J; Forcada J; Hidalgo-Alvarez R
Chem Rev; 2014 Jan; 114(1):367-428. PubMed ID: 24003911
[No Abstract] [Full Text] [Related]
30. Stimuli-responsive smart nanogels for cancer diagnostics and therapy.
Oishi M; Nagasaki Y
Nanomedicine (Lond); 2010 Apr; 5(3):451-68. PubMed ID: 20394537
[TBL] [Abstract][Full Text] [Related]
31. Self-assembled polysaccharide nanogel delivery system for overcoming tumor immune resistance.
Muraoka D; Harada N; Shiku H; Akiyoshi K
J Control Release; 2022 Jul; 347():175-182. PubMed ID: 35526613
[TBL] [Abstract][Full Text] [Related]
32. Addressing the challenge: current and future directions in ovarian cancer therapy.
Kaur T; Slavcev RA; Wettig SD
Curr Gene Ther; 2009 Dec; 9(6):434-58. PubMed ID: 20021329
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
